Guardant Health Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $152.54. The average 1-year stock price forecast is 3.00% lower than the current stock price, while the lowest is $90 (-42.77%) and the highest is $200 (+27.18%).

Price Target: $152.54 (-3.00%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$90	$152.54	$150	$200
Change	-42.77%	-3.00%	-4.61%	+27.18%

Analyst Ratings

The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	17	16	16	16	19	19
Buy	5	5	4	4	5	5
Hold	2	2	2	1	0	0
Sell	0	0	0	1	1	0
Strong Sell	0	0	0	0	0	1
Total	24	23	22	22	25	25

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick B Donnelly Citi	Citi	Buy Maintains $150 → $215	Buy	Maintains	$150 → $215	+36.72%	Jul 8, 2026
Vijay Kumar Evercore ISI	Evercore ISI	Buy Maintains $160 → $200	Buy	Maintains	$160 → $200	+27.18%	Jul 6, 2026
Michael Ryskin Bank of America Securities	Bank of America Securities	Buy Reiterates $135 → $190	Buy	Reiterates	$135 → $190	+20.82%	Jul 6, 2026
Brandon Couillard Wells Fargo	Wells Fargo	Buy Maintains $125	Buy	Maintains	$125	-20.51%	Jul 3, 2026
Evie Koslosky Goldman Sachs	Goldman Sachs	Buy Maintains $165	Buy	Maintains	$165	+4.93%	Jul 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.31B

from 982.02M

33.81%

from 982.02M

Revenue Next Year

1.70B

from 1.31B

29.43%

from 1.31B

EPS This Year

-1.40

from -1.82

EPS Next Year

-0.47

from -1.40

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	373.65M	449.54M	563.95M	739.02M	982.02M	1.31B
Revenue Growth	30.32%	20.31%	25.45%	31.04%	32.88%	33.81%
Gross Profit	250.74M	293.21M	336.90M	449.22M	633.01M	851.94M
Gross Margin	67.11%	65.23%	59.74%	60.79%	64.46%	64.83%
Operating Income	-411.00M	-544.38M	-481.22M	-442.58M	-436.30M	-394.66M
Net Income	-405.67M	-654.59M	-479.45M	-436.37M	-416.28M	-376.95M
EPS	-	-	-	-	-1.82	-1.40
Free Cash Flow	-123.48M	-295.57M	-180.70M	-148.78M	-88.11M	-202.89M
No. Analysts	-	-	-	-	-	23

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.3B
Avg	1.3B
Low	1.3B

Revenue Growth

Revenue Growth	2026	2027	2028
High	34.5%
Avg	33.8%
Low	32.7%

EPS Forecast

EPS	2026	2027	2028
High	-1.14
Avg	-1.40
Low	-1.76

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-